search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
SENSITIVE SKIN 43


Strategies for treating compromised skin


Mélanie Coirier, Elodie Aymard, Hélène Muchico, Brigitte Closs – Silab ABSTRACT


Environmental stresses, age, lifestyle or medicated treatments may compromise the skin and cause the appearance of skin disorders - atopic dermatitis, psoriasis, rosacea, acne - making the skin more sensitive and reactive. In order to provide solutions for compromised skin, Silab launched Silab Softcare department in 2016. By relying on the expertise, innovative capacity and efficiency of the Silab organization, this dedicated department provides solutions specially designed to be used as part of dermo- cosmetic and dermatological care programs. On the occasion of its tenth anniversary, Silab Softcare reinforces its unique approach to research by displaying a novelty, thus increasing its range of effective, safe and natural solutions to three products. The latter have been specifically designed to reactivate the biological mechanisms of cutaneous repair inherent in the proper functioning of healthy skin


Ten years ago, Silab launched Silab Softcare, an in-house department fully dedicated to the care of compromised skin. It develops, manufactures and markets patented active ingredients specifically designed to be used as part of dermo- cosmetic and dermatological care programs. The original positioning of the products


developed by Silab Softcare revolves around strategic focuses, among which: developing original in vitro and in vivo models mimicking the biological process of the pathology, providing proofs of efficacy and proposing natural active molecules, in the form of preservative-free powders. Since its creation, Silab Softcare has dedicated


its research to two chronic dermatological pathologies which today affect a large part of the population: atopic dermatitis and acne. Indeed, epidemiological studies classify atopic dermatitis as a public health problem,1


and acne


as the most widespread skin disorder. Recently, Silab enlarged its research to wound healing, a universal issue of fundamental importance in the field of medical care. Globally, about 300 million patients in fact are afflicted with chronic skin lesions and 100 million patients have traumatic cutaneous wounds.2 This publication aims to highlight the research work conducted by Silab Softcare on these three


www.personalcaremagazine.com


dermatological issues and to identify effective, natural and safe solutions to treat them.


Atopic dermatitis Original in vitro and in vivo models to investigate atopic skin From a molecular standpoint, the major alterations leading to the appearance of atopic dermatitis are an altered barrier function, an exacerbated inflammatory response, a modification of the cutaneous microbiota and neuronal hyperreactivity. To study this pathology, different in vitro and


in vivo models were developed in-house.3-4 First, a model compromised with altered


barrier function was designed. It corresponds to a normal reconstructed epidermis exposed to an inflammatory cocktail prepared with mediators and cytokines characteristic of the disease. It was subjected to additional stress by a solution of sodium lauryl sulfate (SLS) that alters the barrier function. The second model developed was a model


compromised with altered barrier function and colonized by Staphylococcus aureus. This normal reconstructed epidermis was exposed to the same inflammatory cocktail, subjected to additional stress by a solution of sodium lauryl sulfate (SLS) and exposed to aggression by a bacterial


species characteristic of atopic dermatitis (Staphylococcus aureus). In addition, Raman microspectroscopy


was used in vivo to determine the molecular signature of adult volunteers with this pathology in comparison to healthy volunteers. The Raman microspectroscopy studies were carried out by the groups of Professor Arlette Baillet-Guffroy (Analytical Chemistry group, EA4041, University Paris-Sud 11) and Professor Michel Manfait (MeDIAN-CNRS UMR 7369, Reims Champagne- Ardenne School of Pharmacy). This molecular signature directly showed


changes in the lipid component in vivo (organization and conformation) and in the aqueous component (total water, bound water). With atopic dermatitis, there are changes in


the conformation and organization of lipids that reduce the compactness of lipid structures, and the parameters of total water and bound water are significantly reduced. These deteriorations explain the loss of the skin’s barrier properties and also its dryness that is a feature of this pathology.


Development of a natural solution dedicated to atopic skin Thanks to these in vitro and in vivo models, Silab


May 2026 PERSONAL CARE MAGAZINE


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100